Browsing Tag
MASH drug trials
1 post
Cirius Therapeutics shows 0602K and tirzepatide combo preserves muscle and burns fat in obesity and type 2 diabetes
Cirius Therapeutics unveils new ADA 2025 data showing MPC inhibitor 0602K significantly improves muscle and fat metabolism when combined with tirzepatide.